News & Articles

The Roche Diagnostics Tina-quant Lp(a) assay measures lipoprotein (a) in a person’s bloodstream

Discover how modern quality control (QC) principles can enhance operational efficiency and healthcare outcomes

The inaugural BOOM Summit successfully convened 500 participants from across Europe at Messe Basel

The Anti-Müllerian Hormone Assay reveals a patient's ovarian reserve information

Expanding access and screening options to help eliminate cervical cancer with one of the first HPV self-collection solutions in the US

ASTar enables rapid therapeutic response to sepsis directly from a positive blood culture

Highlighting the benefits that point-of-care testing can deliver for cost-efficient healthcare pathways

Partnership aims to expand CE-IVD molecular assay offerings

The new platform promises to substantially lower hands-on time, allowing for increased lab productivity

The new diagnostic system, which combines optofluidics and nanopores can test for COVID-19 and Zika virus

Celebration marks 70 years since the launch of the world’s first commercially available blood gas analyzer

A study suggests that a subtype of Fusobacterium nucleatum underlies colorectal cancer growth in humans and could be useful in screening and treatments

Scopio Labs' third FDA clearance accelerates the shift to AI-powered digital hematopathology, enhancing diagnostic speed and patient care

Discover the human side of laboratory medicine with our #Lab4Life editorial feature

Annual ECCMID congress is now ESCMID Global

Sebia’s CAPILLARYS 3 DBS instrument is an automated, multitasking capillary electrophoresis instrument

The analyzer can now function with new CE-Marked Hepatitis assays announced at ESCMID Global

Supporting earlier Alzheimer's disease diagnosis

Smartphone-sized laboratory – Sepsis IVD grade test based on cutting-edge BioMEMS technology is a joint development objective

The analyzer promises to provide a cost-effective, comprehensive, and reliable solution for rapid point-of-care testing

This is the first four-in-one nucleic acid test for arbovirus screening

Point-of-care HIV diagnostic testing for infants and early detection of HIV infections

The cobas Malaria test is the first FDA-approved molecular test to screen US blood donors for malaria

Clinicians can now get results at the patient's bedside, making the test accessible at urgent care clinics and other healthcare settings

PATHFAST hs-cTnI-II becomes first and only hs-cTn test cleared for point-of-care use in the United States, delivering results up to three times faster than core lab testing